Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/113933
Title: Authorised medicinal products produced using recombinant DNA technology
Authors: Manicaro, Nadia
Serracino-Inglott, Anthony
Sammut Bartolo, Nicolette
Keywords: Recombinant DNA
Pharmaceutical industry -- Quality control
Pharmaceutical technology
Pharmaceutical technology -- Standards -- European Union countries
Issue Date: 2023
Citation: N. Manicaro, A. Serracino-Inglott, & N. Sammut Bartolo (2023). Authorised medicinal products produced using recombinant DNA technology. Poster session at the International Pharmaceutical Federation 81st World Congress of Pharmacy, Brisbane, Australia.
Abstract: The use of genetically modified organisms and technologies such as recombinant DNA (rDNA) technology, enabled opportunities to produce new medicinal products. Along the years, numerous therapies were approved which address therapeutic needs.
URI: https://www.um.edu.mt/library/oar/handle/123456789/113933
Appears in Collections:Scholarly Works - FacM&SPha

Files in This Item:
File Description SizeFormat 
Authorised_medicinal_products_produced_using_recombinant_DNA_technology(2023).pdf185.66 kBAdobe PDFView/Open


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.